Alprazolam, a member of the benzodiazepine class of sedative agents, at low doses typically produces characteristic changes in the resting electroencephalogram (EEG).  This study, involving a cohort of healthy participants, aimed to show that not only could the BAR monitor detect such changes. Results from the trial are due soon.